These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 24589204)
41. The CIREL Cohort: A Prospective Controlled Registry Studying the Real-Life Use of Irinotecan-Loaded Chemoembolisation in Colorectal Cancer Liver Metastases: Interim Analysis. Pereira PL; Iezzi R; Manfredi R; Carchesio F; Bánsághi Z; Brountzos E; Spiliopoulos S; Echevarria-Uraga JJ; Gonçalves B; Inchingolo R; Nardella M; Pellerin O; Sousa M; Arnold D; de Baère T; Gomez F; Helmberger T; Maleux G; Prenen H; Sangro B; Zeka B; Kaufmann N; Taieb J Cardiovasc Intervent Radiol; 2021 Jan; 44(1):50-62. PubMed ID: 32974773 [TBL] [Abstract][Full Text] [Related]
42. Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins? Biolato M; Marrone G; Racco S; Di Stasi C; Miele L; Gasbarrini G; Landolfi R; Grieco A Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):356-62. PubMed ID: 20496548 [TBL] [Abstract][Full Text] [Related]
43. Superselective transarterial chemoembolization for hepatocellular carcinoma: recent progression and perspective. Takayasu K Oncology; 2011; 81 Suppl 1():105-10. PubMed ID: 22212943 [TBL] [Abstract][Full Text] [Related]
44. Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. Marelli L; Stigliano R; Triantos C; Senzolo M; Cholongitas E; Davies N; Yu D; Meyer T; Patch DW; Burroughs AK Cancer Treat Rev; 2006 Dec; 32(8):594-606. PubMed ID: 17045407 [TBL] [Abstract][Full Text] [Related]
45. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead. Poon RT; Tso WK; Pang RW; Ng KK; Woo R; Tai KS; Fan ST Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1100-8. PubMed ID: 17627902 [TBL] [Abstract][Full Text] [Related]
46. Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma. Kudo M; Imanaka K; Chida N; Nakachi K; Tak WY; Takayama T; Yoon JH; Hori T; Kumada H; Hayashi N; Kaneko S; Tsubouchi H; Suh DJ; Furuse J; Okusaka T; Tanaka K; Matsui O; Wada M; Yamaguchi I; Ohya T; Meinhardt G; Okita K Eur J Cancer; 2011 Sep; 47(14):2117-27. PubMed ID: 21664811 [TBL] [Abstract][Full Text] [Related]
48. A randomized phase II study of drug-eluting beads versus transarterial chemoembolization for unresectable hepatocellular carcinoma. van Malenstein H; Maleux G; Vandecaveye V; Heye S; Laleman W; van Pelt J; Vaninbroukx J; Nevens F; Verslype C Onkologie; 2011; 34(7):368-76. PubMed ID: 21734423 [TBL] [Abstract][Full Text] [Related]
49. Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how? Meza-Junco J; Montano-Loza AJ; Liu DM; Sawyer MB; Bain VG; Ma M; Owen R Cancer Treat Rev; 2012 Feb; 38(1):54-62. PubMed ID: 21726960 [TBL] [Abstract][Full Text] [Related]
50. Radioembolisation for liver metastases: results from a prospective 151 patient multi-institutional phase II study. Benson AB; Geschwind JF; Mulcahy MF; Rilling W; Siskin G; Wiseman G; Cunningham J; Houghton B; Ross M; Memon K; Andrews J; Fleming CJ; Herman J; Nimeiri H; Lewandowski RJ; Salem R Eur J Cancer; 2013 Oct; 49(15):3122-30. PubMed ID: 23777743 [TBL] [Abstract][Full Text] [Related]
51. Radioembolisation for treatment of pediatric hepatocellular carcinoma. Hawkins CM; Kukreja K; Geller JI; Schatzman C; Ristagno R Pediatr Radiol; 2013 Jul; 43(7):876-81. PubMed ID: 23212597 [TBL] [Abstract][Full Text] [Related]
52. Trans-arterial chemoembolization as a therapy for liver tumours: New clinical developments and suggestions for combination with angiogenesis inhibitors. Gadaleta CD; Ranieri G Crit Rev Oncol Hematol; 2011 Oct; 80(1):40-53. PubMed ID: 21067940 [TBL] [Abstract][Full Text] [Related]
53. Conventional TACE and drug-eluting bead TACE as locoregional therapy before orthotopic liver transplantation: comparison of explant pathologic response. Frenette CT; Osorio RC; Stark J; Fok B; Boktour MR; Guy J; Rhee J; Osorio RW Transplantation; 2014 Oct; 98(7):781-7. PubMed ID: 24825513 [TBL] [Abstract][Full Text] [Related]
55. Radioembolisation of hepatocellular carcinoma: a primer. Venkatanarasimha N; Gogna A; Tong KTA; Damodharan K; Chow PKH; Lo RHG; Chandramohan S Clin Radiol; 2017 Dec; 72(12):1002-1013. PubMed ID: 29032802 [TBL] [Abstract][Full Text] [Related]
56. Radioembolization in the treatment of neuroendocrine tumors of the pancreas. John PK; Saif MW JOP; 2014 Jul; 15(4):332-4. PubMed ID: 25076336 [TBL] [Abstract][Full Text] [Related]
57. Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumours of the liver. Poggi G; Pozzi E; Riccardi A; Tonini S; Montagna B; Quaretti P; Tagliaferri B; Sottotetti F; Baiardi P; Pagella C; Minoia C; Bernardo G Anticancer Res; 2010 Dec; 30(12):5159-64. PubMed ID: 21187505 [TBL] [Abstract][Full Text] [Related]
58. SBRT, TACE, TARE, or Combined? in the Treatment of Hepatocellular Cancer. Benderli Cihan Y Cancer Biother Radiopharm; 2021 Dec; 36(10):807-808. PubMed ID: 32898438 [No Abstract] [Full Text] [Related]
59. Result and cost of hepatic chemoembolisation with drug eluting beads in 21 patients. Vadot L; Boulin M; Malbranche C; Guiu B; Aho S; Musat A; Pernot C; Guignard MH; Hillon P; Fagnoni P Diagn Interv Imaging; 2013 Jan; 94(1):53-9. PubMed ID: 23146417 [TBL] [Abstract][Full Text] [Related]
60. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy. Bloomston M; Binitie O; Fraiji E; Murr M; Zervos E; Goldin S; Kudryk B; Zwiebel B; Black T; Fargher S; Rosemurgy AS Am Surg; 2002 Sep; 68(9):827-31. PubMed ID: 12356160 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]